Andrew Egger and Jonathan Cohn give their takes on the stunning back-and-forth at the FDA over Moderna’s new mRNA flu vaccine, why the agency initially refused to even review the application, and what ...

The Bulwark is home to Sarah Longwell, Tim Miller, Bill Kristol, JVL, Sam Stein, Catherine Rampell and more. We are the ...

Litigation’s always a gamble, and there was no exception for Sidley Austin as it defended Bayer AG in a dispute with the Federal Trade Commission over Bayer's promotion of its Phillips Colon Health ...

Catherine Rampell and Jonathan Cohn give their takes on Donald Trump’s latest checks to Americans, including $500 payments to some ACA marketplace enrollees and $90 payments to certain Medicare ...

The Solomon Center for Health Law and Policy at Yale Law School, the Yale School of Management, and the Yale School of Public Health hosted a conversation with writer Jonathan Cohn on Sept. 24. The ...

I’ve written a great deal recently about both public-sector pay and public pension finances. Jonathan Cohn defends public-sector workers on both issues in a recent post at the New Republic. Cohn makes ...

Wednesday's health care summit produced a media orgy of "who's up-who's down" punditry. Treating it as a mere sporting event misses the mark, however. Sports have objective rules to differentiate ...

It's been rough going for the "public option" this afternoon. But Jonathan Cohn, The New Republic's resident health care wonk, finds cause for optimism even in the event--dreaded by most ...